about
Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunctionArachidonic acid and Docosahexanoic acid enhance platelet formation from human apheresis-derived CD34+ cells.Biosimilar granulocyte-colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor.A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors.Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.Hematopoietic growth factors in transfusion medicine and cellular therapy - part I.Granulocyte-colony stimulating factor administration among hemoglobin S trait donors: A single center experience from the Eastern Mediterranean region.Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors.Use of plerixafor to mobilize a healthy donor infected with influenza A.Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation.Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injuryAssessment of Neutrophil Chemotaxis Upon G-CSF Treatment of Healthy Stem Cell Donors and in Allogeneic Transplant Recipients
P2860
Q24185847-C2EBD748-B15C-460C-A3D2-9D687E8C04FEQ33440774-DB842C19-F318-4C76-9766-B0FA29D1ED55Q35835005-2B56B967-80D3-4DBE-BB01-1F2231981C2AQ37508110-7A5735B5-4F5A-44D9-86F2-26401D1B3318Q38323097-A19973A2-077B-4914-8E78-F0E4A24BCD08Q40727125-DA9EB85F-D463-414A-95BC-6BE11CA28117Q41485866-3E3C66DB-AD55-4718-B1B8-1FB1CE93A767Q42085680-E7B49251-1B09-4F34-B685-74E8AFE3E514Q48140002-2E23D963-101D-4A9A-823E-2F313C188275Q48192483-A2B41AB6-FEF0-4413-A30F-7B388A22B614Q49390737-89A37A57-C354-4D39-A137-3F0E4A19BB38Q50463607-BD5A6DEF-5C35-4F84-B80B-096D6FE3E33AQ51099240-B8CDA389-0851-44C1-A2B2-A4312B999B92Q57153034-C3707D75-7A4E-4853-911D-8F994C69C5D3Q58750700-9C675C77-217C-4F52-94B5-C22523570D76
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
G-CSF in Healthy Allogeneic Stem Cell Donors.
@en
G-CSF in Healthy Allogeneic Stem Cell Donors.
@nl
type
label
G-CSF in Healthy Allogeneic Stem Cell Donors.
@en
G-CSF in Healthy Allogeneic Stem Cell Donors.
@nl
prefLabel
G-CSF in Healthy Allogeneic Stem Cell Donors.
@en
G-CSF in Healthy Allogeneic Stem Cell Donors.
@nl
P2860
P356
P1476
G-CSF in Healthy Allogeneic Stem Cell Donors.
@en
P2093
Kristina Hölig
P2860
P304
P356
10.1159/000354196
P577
2013-07-22T00:00:00Z